
Dr Joseph Sarret has joined commercial-stage US biopharma firm Corium International in the newly-created position of chief business officer.
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

